PDL BioPharma (NYSE: PDLI) announced it will no longer actively pursue the sale of the company or its biotechnology discovery and development assets.
PDLI is recently down $2.96 to $12.88 in pre-open trading.
PDLI overall option implied volatility of 41 is above its 26-week average of 37 according to Track Data, suggesting slightly larger price movement.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com










